Cargando…
Computational design of a synthetic PD-1 agonist
Programmed cell death protein-1 (PD-1) expressed on activated T cells inhibits T cell function and proliferation to prevent an excessive immune response, and disease can result if this delicate balance is shifted in either direction. Tumor cells often take advantage of this pathway by overexpressing...
Autores principales: | Bryan, Cassie M., Rocklin, Gabriel J., Bick, Matthew J., Ford, Alex, Majri-Morrison, Sonia, Kroll, Ashley V., Miller, Chad J., Carter, Lauren, Goreshnik, Inna, Kang, Alex, DiMaio, Frank, Tarbell, Kristin V., Baker, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307378/ https://www.ncbi.nlm.nih.gov/pubmed/34272285 http://dx.doi.org/10.1073/pnas.2102164118 |
Ejemplares similares
-
Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity
por: Noubade, Rajkumar, et al.
Publicado: (2019) -
An enumerative algorithm for de novo design of proteins with diverse pocket structures
por: Basanta, Benjamin, et al.
Publicado: (2020) -
Improving de novo protein binder design with deep learning
por: Bennett, Nathaniel R., et al.
Publicado: (2023) -
Influence of the Synthetic Cannabinoid Agonist on Normal and Inflamed Cartilage: An In Vitro Study
por: Shang, Jiangyinzi, et al.
Publicado: (2023) -
Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity
por: Hu, Xiao, et al.
Publicado: (2016)